These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 20638581)
21. Current methods of prenatal screening for Down syndrome and other fetal abnormalities. Saller DN; Canick JA Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497 [TBL] [Abstract][Full Text] [Related]
23. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
24. Down syndrome: prenatal risk assessment and diagnosis. Newberger DS Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860 [TBL] [Abstract][Full Text] [Related]
25. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
26. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
27. Second-trimester minor ultrasound anomalies: impact on the risk of aneuploidy associated with advanced maternal age. Drugan A; Johnson MP; Reichler A; Hume RF; Itskovicz-Eldor J; Evans MI Obstet Gynecol; 1996 Aug; 88(2):203-6. PubMed ID: 8692502 [TBL] [Abstract][Full Text] [Related]
28. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related]
29. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers]. Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254 [TBL] [Abstract][Full Text] [Related]
30. Fetal nucleated red blood cell counts in peripheral blood of mothers bearing Down syndrome fetus. Parano E; Falcidia E; Grillo A; Takabayashi H; Trifiletti RR; Pavone P Neuropediatrics; 2001 Jun; 32(3):147-9. PubMed ID: 11521211 [TBL] [Abstract][Full Text] [Related]
31. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study. Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548 [TBL] [Abstract][Full Text] [Related]
32. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Benn P; Borell A; Chiu R; Cuckle H; Dugoff L; Faas B; Gross S; Johnson J; Maymon R; Norton M; Odibo A; Schielen P; Spencer K; Huang T; Wright D; Yaron Y Prenat Diagn; 2013 Jul; 33(7):622-9. PubMed ID: 23616385 [No Abstract] [Full Text] [Related]
33. Down Syndrome: what do pregnant women know about their individual risk? A prospective trial. Strauss A; Heer IM; Spelsberg F; Strauss C Arch Gynecol Obstet; 2013 Jun; 287(6):1119-23. PubMed ID: 23334105 [TBL] [Abstract][Full Text] [Related]
34. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21. Maxwell S; James I; Dickinson JE; O'Leary P Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261 [TBL] [Abstract][Full Text] [Related]
35. Revisiting absent nasal bone in the second trimester. Singh C; Thakur S; Arora N; Khurana D J Clin Ultrasound; 2021 Jan; 49(1):3-7. PubMed ID: 32521052 [TBL] [Abstract][Full Text] [Related]
36. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Yeo L; Vintzileos AM Semin Perinatol; 2003 Apr; 27(2):152-9. PubMed ID: 12769201 [TBL] [Abstract][Full Text] [Related]
37. An assessment of the Down syndrome antenatal screening policies of East and West Gloucestershire between 1993 and 1999. Dixon J; Pillai M; Mahendran D; Brooks M J Obstet Gynaecol; 2004 Oct; 24(7):760-4. PubMed ID: 15763782 [TBL] [Abstract][Full Text] [Related]
38. Prenatal screening and diagnosis of aneuploidy in multiple pregnancies. Gagnon A; Audibert F Best Pract Res Clin Obstet Gynaecol; 2014 Feb; 28(2):285-94. PubMed ID: 24485166 [TBL] [Abstract][Full Text] [Related]
39. Survey of second-trimester maternal serum screening in Japan. Okuyama T; Yotsumoto J; Funato Y J Obstet Gynaecol Res; 2013 May; 39(5):942-7. PubMed ID: 23509876 [TBL] [Abstract][Full Text] [Related]
40. Second-trimester genetic sonography in patients with advanced maternal age and normal triple screen. Vintzileos AM; Guzman ER; Smulian JC; Yeo L; Scorza WE; Knuppel RA Obstet Gynecol; 2002 Jun; 99(6):993-5. PubMed ID: 12052588 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]